FDA Inspection 676775 — Baxter Pharmaceuticals India Pvt Ltd

Baxter Pharmaceuticals India Pvt Ltd — FEI 3004610460

The FDA completed an inspection of Baxter Pharmaceuticals India Pvt Ltd on June 16, 2010 in Ahmedabad. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 16, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)